CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.
about
Review: The Lacrimal Gland and Its Role in Dry EyeLymphatic Vessels, Inflammation, and Immunity in Skin CancerImmunological aspects of acute and recurrent herpes simplex keratitisAsymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral ImmunityCorneal lymphangiogenesis in herpetic stromal keratitisIL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity.HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgeniThe Current State of Vaccine Development for Ocular HSV-1 InfectionTherapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of lA Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in MiceCornea lymphatics drive the CD8+ T-cell response to herpes simplex virus-1.Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against OculMurine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy.CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?Lymphangiogenesis in renal diseases: passive bystander or active participant?Challenges of corneal infections.The function of regulatory T cells at the ocular surface: Review.Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection.Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107 CD8 T Cells That Infiltrate the Corneas and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protect ag
P2860
Q26752722-B502B775-D281-4BAB-9846-C9F00636E591Q26778332-D9202932-D942-4DA4-AF4C-FE2352B74AF3Q27016103-6C1EE621-13C0-4384-8E93-D5C795345CDDQ33755236-1D6FCB95-7153-4B38-A19D-10141DE98520Q34520389-1E841A5E-D83A-4046-8651-49AC15577DC4Q34674612-39A06844-9344-4F77-BEC2-7BD28A6A5B88Q34749483-7F1BC956-52A6-45DC-A765-C7D6DADB87E6Q34881185-BD21F83F-ECA1-41CE-A953-76B41ED28D0BQ35122383-95AFF120-0A9F-4308-A93D-CAC1EA5AE6F6Q35606611-197A2535-F2EE-4C5B-8446-880A3C09542EQ35745358-420040FB-92EE-44B3-AE64-3827C20D508FQ35769258-9A0E7F18-5476-4697-9DDF-6AD44440E993Q36124928-337541DA-4FEC-4B5E-8AA3-081150710C26Q37553079-51294B8F-4946-4639-8583-DD52A173A897Q37560770-01444616-F879-4709-987A-78825AE9D955Q37600490-648C46BC-B88F-41FD-BBDD-22D915AC0082Q37623874-AAA33BA8-4B7E-4106-8AD4-73FAF21D900EQ37699104-37C44CB9-E3D7-4F5D-B27E-48D0ABD1E7D4Q38123280-B85A3E1D-DA63-4A95-BC6B-EFBC171A8404Q38254023-D6796F30-03E6-48F9-AA8B-634F17B4E36BQ39019254-58A934C7-C648-4BF0-A329-515EEABE4FFAQ39347374-D1E46C86-456C-4DF2-9DE8-54AAA75BFA32Q39644780-C3046077-CA1E-4F2A-A307-0FB50279C47EQ40216595-26CDD363-498C-4880-BF7A-E56EC7138291Q40257434-24B8760F-EA2C-43F5-B5C8-500107036A69Q47554197-4F144C87-3933-4733-B344-2D15F1B4A169Q57753552-544B8698-1053-4DDA-9DC2-D979E3927145
P2860
CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CD8+ T cells suppress viral re ...... uced lymphatic vessel genesis.
@ast
CD8+ T cells suppress viral re ...... uced lymphatic vessel genesis.
@en
type
label
CD8+ T cells suppress viral re ...... uced lymphatic vessel genesis.
@ast
CD8+ T cells suppress viral re ...... uced lymphatic vessel genesis.
@en
prefLabel
CD8+ T cells suppress viral re ...... uced lymphatic vessel genesis.
@ast
CD8+ T cells suppress viral re ...... uced lymphatic vessel genesis.
@en
P2093
P2860
P356
P1476
CD8+ T cells suppress viral re ...... uced lymphatic vessel genesis.
@en
P2093
Christopher D Conrady
Daniel J J Carr
Donald U Stone
P2860
P304
P356
10.4049/JIMMUNOL.1200063
P407
P577
2012-05-30T00:00:00Z